Relay Therapeutics Inc (RLAY)

NASDAQ

$19.18

Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.

Sector:

Industry:

68 analysts

Buy

Target: $25.38 (+32.33%)

Market Cap

$3.69B

FCF 5Y CAGR

+43.64%

Free Cash Flow Yield

-5.78%

Beta (5Y)

1.84

Adjust inflation

Log

Valuation

Market Cap$3.69B

P/S398.28

P/B6.48

Profitability

Total Revenue (TTM)$11M

Gross Profit (TTM)-$246M

EBITDA-$294M

Operating Margin-2620%

EPS-$1.54

Financial Health

Free Cash Flow Yield-5.78%

Growth & Risk

Revenue 5Y CAGR-33.74%

FCF 5Y CAGR+43.64%

Beta (5Y)1.84

Sharpe Ratio2.64